SENSEX 83878.17 (0.36)
Nifty Bank 59450.5 (0.34)
Nifty Smallcap 100 17193.3 (-0.52)
Nifty Next 50 68699.05 (0.30)
Nifty Pharma 22668.45 (-0.41)
Nifty IT 37988.25 (-0.10)
Nifty Midcap 100 59717.1 (-0.05)
Nifty 50 25790.25 (0.42)
NIKKEI 225 53537.3 (3.08)
HANG SENG 26974.5 (1.38)
S&P 6997.71 (0.15)
01-Aug-2024
Sales up 9%, net up 8%
'Consolidated net sales (including other operating income) of KSB for the quarter ended Jun 2024 has increased 9.25% to Rs 646 crore. Operating profit margin has declined from 14.41% to 14.02%, leading to 6.34% rise in operating profit to Rs 90.60 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 47.06% to 45.13%. Purchase of finished goods cost rose from 10.04% to 10.86%. Employee cost increased from 11.09% to 11.79%. Other expenses rose from 17.66% to 18.08%. Other income rose 17.28% to Rs 9.5 crore. PBIDT rose 7.29% to Rs 100.1 crore. Provision for interest fell 11.11% to Rs 0.8 crore. PBDT rose 7.47% to Rs 99.3 crore. Provision for depreciation rose 10.83% to Rs 13.3 crore. Profit before tax grew 6.97% to Rs 86.00 crore. Share of profit/loss was 44.44% higher at Rs 3.9 crore. Provision for tax was expense of Rs 21...
(13-Jan-2026)
Revenue up 13.3% YoY to Rs 33872 crore in Q3FY2026
Revenue up 4.9% YoY to Rs 67087 crore in Q3FY2026
(12-Jan-2026)
Revenue up 116.8% YoY to Rs 659 crore in Q3FY2026
(11-Jan-2026)
Revenue up 13.3% YoY to Rs 18100.9 crore, Net profit up 18.3% yoy to Rs 855.9 crore in Q3FY2026
Results-Analysis (20-Aug-2025)
Sales up 3%, net up 3%
Results-Analysis (30-Apr-2025)
Sales up 9%, net up 16%
Analyst Meet / AGM-Conference Call (06-Mar-2025)
Order intake was higher in CY2024 compared to last year
Results-Analysis (28-Feb-2025)
Net up 33% largely on higher sales, higher OI and lower taxation